Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects

References

• MohamedQGilliesMCWongTYManagement of diabetic retinopathy: a systematic reviewJAMA2007298890291617712074
   PubMed Web of Science ®Google Scholar
• ZhongXDuYLeiYLiuNGuoYPanTEffects of vitamin D receptor gene polymorphism and clinical characteristics on risk of diabetic retinopathy in Han Chinese type 2 diabetes patientsGene2015566221221625899017
   PubMed Web of Science ®Google Scholar
• SasongkoMBWongTYNguyenTTCheungCYShawJEWangJJRetinal vascular tortuosity in persons with diabetes and diabetic retinopathyDiabetologia20115492409241621625945
   PubMed Web of Science ®Google Scholar
• CheungNMitchellPWongTYDiabetic retinopathyLancet2010376973512413620580421
   PubMed Web of Science ®Google Scholar
• BhavsarARDiabetic Retinopathy [webpage on the Internet]New YorkWebMD LLC [upated April 1, 2015]. Available from: http://emedicine.medscape.com/article/1225122-overview#showallAccessed July 7, 2015
   Google Scholar
• ImaiHSinghRSFortPEGardnerTWNeuroprotection for diabetic retinopathyDev Ophthalmol200944566819494653
   PubMedGoogle Scholar
• LeeYWongTYSabanayagamCEpidemiology of diabetic retinopa-thy, diabetic macular edema and related vision lossEye Vis (Lond)201521726605370
   PubMedGoogle Scholar
• International Diabetes FederationAnnual Report 2013BrusselsInternational Diabetes Federation2014 Available from: http://www.idf.org/sites/default/files/attachments/IDF-AR2013-final-rv.pdfAccessed August 29, 2015
   Google Scholar
• SafiSZQvistRKumarSBatumalaieKIsmailISMolecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targetsBiomed Res Int2014201480126925105142
   PubMed Web of Science ®Google Scholar
• YauJWRogersSLKawasakiRMeta-Analysis for Eye Disease (META-EYE) Study GroupGlobal prevalence and major risk factors of diabetic retinopathyDiabetes Care201235355656422301125
   PubMed Web of Science ®Google Scholar
• LorenziMThe polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilientExp Diabetes Res200720076103818224243
   PubMedGoogle Scholar
• ObrosovaIGKadorPFAldose reductase/polyol inhibitors for diabetic retinopathyCurr Pharm Biotechnol201112337338520939801
   PubMed Web of Science ®Google Scholar
• SternDMYanSDYanSFSchmidtAMReceptor for advanced glycation endproducts (RAGE) and the complications of diabetesAgeing Res Rev20021111512039445
   PubMed Web of Science ®Google Scholar
• AhmedNAdvanced glycation endproducts – role in pathology of diabetic complicationsDiabetes Res Clin Pract200567132115620429
   PubMed Web of Science ®Google Scholar
• TarrJMKaulKChopraMKohnerEMChibberRPathophysiology of diabetic retinopathyISRN Ophthalmol2013201334356024563789
   PubMedGoogle Scholar
• AgrawalSSNaqviSGuptaSKSrivastavaSPrevention and management of diabetic retinopathy in STZ diabetic rats by Tinospora cordifolia and its molecular mechanismsFood Chem Toxicol20125093126313222687550
   PubMed Web of Science ®Google Scholar
• AhmedKAMuniandySIsmailISType 2 diabetes and vascular complications: a pathophysiologic viewBiomedical Research201021147155
   Google Scholar
• RemaMPradeepaRDiabetic retinopathy: an Indian perspectiveIndian J Med Res2007125329731017496357
   PubMed Web of Science ®Google Scholar
• GiaccoFBrownleeMOxidative stress and diabetic complicationsCirc Res201010791058107021030723
   PubMed Web of Science ®Google Scholar
• HalimEMMukhopadhyayAKEffect of Ocimum sanctum (Tulsi) and vitamin E on biochemical parameters and retinopathy in streptozotocin induced diabetic ratsIndian J Clin Biochem2006212181188
   PubMedGoogle Scholar
• OlaMSNawazMISiddiqueiMMAl-AmroSAbu El-AsrarAMRecent advances in understanding the biochemical and molecular mechanism of diabetic retinopathyJ Diabetes Complications2012261566422226482
   PubMed Web of Science ®Google Scholar
• HoriSDiabetic retinopathyNihon Rinsho200563Suppl 2620624 Japanese15779450
   PubMedGoogle Scholar
• KumarBGuptaSKNagTCRetinal neuroprotective effects of quercetin in streptozotocin-induced diabetic ratsExp Eye Res201412519320224952278
   PubMed Web of Science ®Google Scholar
• KowluruRAKowluruVXiongYHoYSOverexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stressFree Radic Biol Med20064181191119617015165
   PubMed Web of Science ®Google Scholar
• KumarBGuptaSKSrinivasanBPHesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic ratsMicrovasc Res201387657423376836
   PubMed Web of Science ®Google Scholar
• KowluruRAKanwarMEffects of curcumin on retinal oxidative stress and inflammation in diabetesNutr Metab (Lond)20074817437639
   PubMed Web of Science ®Google Scholar
• KowluruRAChanPSOxidative stress and diabetic retinopathyExp Diabetes Res200720074360317641741
   PubMedGoogle Scholar
• JoussenAMPoulakiVLeMLA central role for inflammation in the pathogenesis of diabetic retinopathyFASEB J200418121450145215231732
   PubMed Web of Science ®Google Scholar
• IbrahimASEl-ShishtawyMMPeñaAJrLiouGIGenistein attenuates retinal inflammation associated with diabetes by targeting of microglial activationMol Vis2010162033204221042558
   PubMed Web of Science ®Google Scholar
• GuptaSKKumarBNagTCCurcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanismsJ Ocul Pharmacol Ther201127212313021314438
   PubMed Web of Science ®Google Scholar
• ElmarakbyAAIbrahimASFaulknerJMozaffariMSLiouGIAbdelsayedRTyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic miceVascul Pharmacol2011555–614915621807121
   PubMed Web of Science ®Google Scholar
• ObrosovaIGMinchenkoAGVasupuramRAldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic ratsDiabetes200352386487112606532
   PubMed Web of Science ®Google Scholar
• MyśliwiecMBalcerskaAZorenaKMyśliwskaJLipowskiPRaczyńskaKThe role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathyDiabetes Res Clin Pract200879114114617716775
   PubMed Web of Science ®Google Scholar
• RobinsonRBarathiVAChaurasiaSSWongTYKernTSUpdate on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammalsDis Model Mech20125444445622730475
   PubMed Web of Science ®Google Scholar
• WolterJRDiabetic retinopathyAm J Ophthalmol1961511123114113786453
   PubMed Web of Science ®Google Scholar
• BloodworthJMJrDiabetic retinopathyDiabetes1963129911413971778
   PubMed Web of Science ®Google Scholar
• StemMSGardnerTWNeurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implicationsCurr Med Chem201320263241325023745549
   PubMed Web of Science ®Google Scholar
• YuYChenHSuSBNeuroinflammatory responses in diabetic retinopathyJ Neuroinflammation20151214126245868
   PubMed Web of Science ®Google Scholar
• KleinRKleinBEMossSECruickshanksKJThe Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetesOphthalmology199810510180118159787347
   PubMed Web of Science ®Google Scholar
• CetinENBulguYOzdemirSAssociation of serum lipid levels with diabetic retinopathyInt J Ophthalmol20136334634923826531
   PubMed Web of Science ®Google Scholar
• FerrisFL3rdChewEYHoogwerfBJSerum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research GroupDiabetes Care19961911129112938908399
   PubMed Web of Science ®Google Scholar
• RemaMSrivastavaBKAnithaBDeepaRMohanVAssociation of serum lipids with diabetic retinopathy in urban South Indians – The Chennai Urban Rural Epidemiology Study (CURES) Eye Study – 2Diabet Med20062391029103616922712
   PubMed Web of Science ®Google Scholar
• SinghRDashDAnsariFJMauryaOPSinghVPAldose reductase and diabetic retinopathyAnn Ophthalmol199224114204221476398
   PubMedGoogle Scholar
• BrownleeMThe pathobiology of diabetic complications: a unifying mechanismDiabetes20055461615162515919781
   PubMed Web of Science ®Google Scholar
• AlghadyanAADiabetic retinopathy – an updateSaudi J Ophthalmol20112529911123960911
   PubMedGoogle Scholar
• DemircanNSafranBGSoyluMOzcanAASizmazSDetermination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathyEye (Lond)200620121366136916284605
   PubMed Web of Science ®Google Scholar
• DoganaySEverekliogluCErHComparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitusEye (Lond)200216216317011988817
   PubMed Web of Science ®Google Scholar
• KleinmanMEBaffiJZAmbatiJThe multifactorial nature of retinal vascular diseaseOphthalmologica2010224Suppl 11624
   PubMed Web of Science ®Google Scholar
• RoySHaJTrudeauKBeglovaEVascular basement membrane thickening in diabetic retinopathyCurr Eye Res201035121045105620929292
   PubMed Web of Science ®Google Scholar
• AndersonHRStittAWGardinerTAArcherDBDiabetic retinopathy: morphometric analysis of basement membrane thickening of capillaries in different retinal layers within arterial and venous environmentsBr J Ophthalmol199579112011238562548
   PubMed Web of Science ®Google Scholar
• RayBSPazianosAGGreenbergEPeretzWLMcLeanJMPituitary ablation for diabetic retinopathy. I. Results of hypophysectomy. (A ten-year evaluation)JAMA1968203279845694074
   PubMed Web of Science ®Google Scholar
• KollerEAGreenLGertnerJMBostMMalozowskiSNRetinal changes mimicking diabetic retinopathy in two nondiabetic, growth hormone-treated patientsJ Clin Endocrinol Metab1998837238023839661613
   PubMed Web of Science ®Google Scholar
• StittAWBhaduriTMcMullenCBGardinerTAArcherDBAdvanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic ratsMol Cell Biol Res Commun20003638038811032761
   PubMedGoogle Scholar
• GohSYCooperMEClinical review: the role of advanced glycation end products in progression and complications of diabetesJ Clin Endocrinol Metab20089341143115218182449
   PubMed Web of Science ®Google Scholar
• KowluruRAEffect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic ratsDiabetes200352381882312606525
   PubMed Web of Science ®Google Scholar
• PanHZZhangHChangDLiHSuiHThe change of oxidative stress products in diabetes mellitus and diabetic retinopathyBr J Ophthalmol200892454855118369071
   PubMed Web of Science ®Google Scholar
• da SilvaSBCostaJPPintadoMEFerreiraDCSarmentoBAntioxidants in the prevention and treatment of diabetic retinopathy – a reviewJ Diabetes Metab20101111
   Google Scholar
• LastaMPempBSchmidlDNeurovascular dysfunction precedes neural dysfunction in the retina of patients with type 1 diabetesInvest Ophthalmol Vis Sci201354184284723307962
   PubMed Web of Science ®Google Scholar
• GarhöferGZawinkaCReschHKothyPSchmettererLDornerGTReduced response of retinal vessel diameters to flicker stimulation in patients with diabetesBr J Ophthalmol200488788789115205231
   PubMed Web of Science ®Google Scholar
• BekTHajariJJeppesenPInteraction between flicker-induced vasodilatation and pressure autoregulation in early retinopathy of type 2 diabetesGraefes Arch Clin Exp Ophthalmol2008246576376918265996
   PubMed Web of Science ®Google Scholar
• LottMESlocombJEShivkumarVComparison of retinal vasodilator and constrictor responses in type 2 diabetesActa Ophthalmol2012906e434e44122682034
   PubMed Web of Science ®Google Scholar
• AntonettiDAKleinRGardnerTWDiabetic retinopathyN Engl J Med2012366131227123922455417
   PubMed Web of Science ®Google Scholar
• NgJSBearseMAJrSchneckMEBarezSAdamsAJLocal diabetic retinopathy prediction by multifocal ERG delays over 3 yearsInvest Ophthalmol Vis Sci20084941622162818385083
   PubMed Web of Science ®Google Scholar
• HarrisonWWBearseMAJrNgJSMultifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetesInvest Ophthalmol Vis Sci201152277277720926810
   PubMed Web of Science ®Google Scholar
• GualtieriMBandeiraMHamerRDDamicoFMMouraALVenturaDFContrast sensitivity mediated by inferred magno- and parvocellular pathways in type 2 diabetics with and without nonproliferative retinopathyInvest Ophthalmol Vis Sci20115221151115521051718
   PubMed Web of Science ®Google Scholar
• JacksonGRScottIUQuillenDAWalterLEGardnerTWInner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathyBr J Ophthalmol201296569970322174096
   PubMed Web of Science ®Google Scholar
• GreensteinVCThomasSRBlausteinHKoenigKCarrREEffects of early diabetic retinopathy on rod system sensitivityOptom Vis Sci199370118238430004
   PubMed Web of Science ®Google Scholar
• ParravanoMOddoneFMineoDThe role of Humphrey Matrix testing in the early diagnosis of retinopathy in type 1 diabetesBr J Ophthalmol200892121656166018829632
   PubMed Web of Science ®Google Scholar
• ParkHYKimITParkCKEarly diabetic changes in the nerve fibre layer at the macula detected by spectral domain optical coherence tomographyBr J Ophthalmol20119591223122821216799
   PubMed Web of Science ®Google Scholar
• van DijkHWVerbraakFDKokPHDecreased retinal ganglion cell layer thickness in patients with type 1 diabetesInvest Ophthalmol Vis Sci20105173660366520130282
   PubMed Web of Science ®Google Scholar
• ReiterCEGardnerTWFunctions of insulin and insulin receptor signaling in retina: possible implications for diabetic retinopathyProg Retin Eye Res200322454556212742394
   PubMed Web of Science ®Google Scholar
• RajalaRVPhosphoinositide 3-kinase signaling in the vertebrate retinaJ Lipid Res201051142219638643
   PubMed Web of Science ®Google Scholar
• RajalaRVAndersonRERhodopsin-regulated insulin receptor signaling pathway in rod photoreceptor neuronsMol Neurobiol2010421394720407846
   PubMed Web of Science ®Google Scholar
• FortPELosiewiczMKReiterCEDifferential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistancePLoS One2011610e2649822046295
   PubMed Web of Science ®Google Scholar
• BarberAJLiethEKhinSAAntonettiDABuchananAGGardnerTWNeural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulinJ Clin Invest199810247837919710447
   PubMed Web of Science ®Google Scholar
• LiethEBarberAJXuBGlial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research GroupDiabetes19984758158209588455
   PubMed Web of Science ®Google Scholar
• ZhangYBhavnaniBRGlutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogensBMC Neurosci200674916776830
   PubMed Web of Science ®Google Scholar
• PulidoJEPulidoJSErieJCA role for excitatory amino acids in diabetic eye diseaseExp Diabetes Res200720073615017713594
   PubMedGoogle Scholar
• LiuYLeoLFMcGregorCGrivitishviliABarnstableCJTombran-TinkJPigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) miceMol Med2012181387140123019073
   PubMed Web of Science ®Google Scholar
• YoshidaYYamagishiSMatsuiTProtective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathyDiabetes Metab Res Rev200925767868619685553
   PubMed Web of Science ®Google Scholar
• BarnstableCJTombran-TinkJNeuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potentialProg Retin Eye Res200423556157715302351
   PubMed Web of Science ®Google Scholar
• ShenXXieBChengYJiaoQZhongYEffect of pigment epithelium derived factor on the expression of glutamine synthetase in early phase of experimental diabetic retinopathyOcul Immunol Inflamm201119424625421770802
   PubMed Web of Science ®Google Scholar
• GongYChangZPRenRTProtective effects of adeno-associated virus mediated brain-derived neurotrophic factor expression on retinal ganglion cells in diabetic ratsCell Mol Neurobiol201232346747522297541
   PubMed Web of Science ®Google Scholar
• SekiMTanakaTNawaHInvolvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cellsDiabetes20045392412241915331553
   PubMed Web of Science ®Google Scholar
• HammesHPFederoffHJBrownleeMNerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetesMol Med1995155275348529118
   PubMed Web of Science ®Google Scholar
• AliTKAl-GayyarMMMatragoonSDiabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injuryDiabetologia201154365766820957344
   PubMed Web of Science ®Google Scholar
• BarberAJGardnerTWAbcouwerSFThe significance of vascular and neural apoptosis to the pathology of diabetic retinopathyInvest Ophthalmol Vis Sci20115221156116321357409
   PubMed Web of Science ®Google Scholar
• BandayMZBashirAHaqEMolecular pathobiology of diabetic retinopathyBioresearch Bulletin20103102115
   Google Scholar
• NunesSPiresIRosaADuarteLBernardesRCunha-VazJMicroaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathyOphthalmologica2009223529229719372723
   PubMed Web of Science ®Google Scholar
• HaritoglouCKerntMNeubauerAMicroaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathyRetina201434115716423792485
   PubMed Web of Science ®Google Scholar
• RibeiroLBandelloFTejerinaANEvicr Net Study GroupCharacterization of retinal disease progression in a 1-year longitudinal study of eyes with mild nonproliferative retinopathy in diabetes type 2Invest Ophthalmol Vis Sci20155695698570526322834
   PubMed Web of Science ®Google Scholar
• HernándezOHGarcía-MartínezRLizana-HenríquezCOptical coherence tomography and visual evoked potentials in patients with type 2 diabetes with and without retinopathy: preliminary reportRev Invest Clin2014664330338 Spanish25695298
   PubMedGoogle Scholar
• VirgiliGMenchiniFCasazzaGOptical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathyCochrane Database Syst Rev20151CD00808125564068
   PubMed Web of Science ®Google Scholar
• JanssonRWRaederMBKrohnJPhotopic full-field electroretinography and optical coherence tomography in type 1 diabetic retinopathyGraefes Arch Clin Exp Ophthalmol2015253798999726004074
   PubMed Web of Science ®Google Scholar
• SimDAKeanePAZarranz-VenturaJPredictive factors for the progression of diabetic macular ischemiaAm J Ophthalmol2013156468469223891332
   PubMed Web of Science ®Google Scholar
• HellgrenKJAgardhEBengtssonBProgression of early retinal dysfunction in diabetes over time: results of a long-term prospective clinical studyDiabetes20146393104311124848062
   PubMed Web of Science ®Google Scholar
• HellgrenKJBengtssonBAgardhEFunctional and structural change in diabetic eyes. Interim results from an ongoing longitudinal prospective studyActa Ophthalmol201391767267723025256
   PubMed Web of Science ®Google Scholar
• SimDAKeanePARajendramRPatterns of peripheral retinal and central macula ischemia in diabetic retinopathy as evaluated by ultra-widefield fluorescein angiographyAm J Ophthalmol20141581144153e124709807
   PubMed Web of Science ®Google Scholar
• SilvaPSCavalleranoJDSunJKSolimanAZAielloLMAielloLPPeripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severityOphthalmology2013120122587259523778092
   PubMed Web of Science ®Google Scholar
• SchollHPZrennerEElectrophysiology in the investigation of acquired retinal disordersSurv Ophthalmol2000451294710946080
   PubMed Web of Science ®Google Scholar
• BearseMAJrOzawaGYMultifocal electroretinography in diabetic retinopathy and diabetic macular edemaCurr Diab Rep201414952625005120
   PubMed Web of Science ®Google Scholar
• KinshuckDHbA1C and Retinopathy [webpage on the Internet] Available from: http://www.diabeticretinopathy.org.uk/prevention/hba1c_and_retinopathy.htmAccessed July 6, 2015
   Google Scholar
• No authors listedThe relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trialDiabetes19954489689837622004
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research GroupEarly worsening of diabetic retinopathy in the Diabetes Control and Complications TrialArch Ophthalmol199811678748869682700
   PubMed Web of Science ®Google Scholar
• UKPDS Prospective Diabetes Research GroupTight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study GroupBMJ199831771607037139732337
   PubMed Web of Science ®Google Scholar
• van LeidenHADekkerJMMollACBlood pressure, lipids, and obesity are associated with retinopathy: the hoorn studyDiabetes Care20022581320132512145228
   PubMed Web of Science ®Google Scholar
• MatthewsDRStrattonIMAldingtonSJHolmanRRKohnerEMUK Prospective Diabetes Study GroupRisks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69Arch Ophthalmol2004122111631164015534123
   PubMedGoogle Scholar
• SjølieAKPortaMParvingHHBilousRKleinRDIRECT Programme Study GroupThe DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristicsJ Renin Angiotensin Aldosterone Syst200561253216088848
   PubMed Web of Science ®Google Scholar
• ChaturvediNSjolieAStephensonJMEffect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes MellitusLancet199835128319433426
   PubMed Web of Science ®Google Scholar
• KeechASimesRJBarterPFIELD study investigatorsEffects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialLancet200536695001849186116310551
   PubMed Web of Science ®Google Scholar
• SenKMisraAKumarAPandeyRMSimvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemiaDiabetes Res Clin Pract20025611111879715
   PubMed Web of Science ®Google Scholar
• RohanTEFrostCDWaldNJPrevention of blindness by screening for diabetic retinopathy: a quantitative assessmentBMJ19892996709119812012513049
   PubMed Web of Science ®Google Scholar
• No authors listedPhotocoagulation for proliferative diabetic retinopathy: a randomised controlled clinical trial using the xenon-arcDiabetologia19842621091156201409
   PubMed Web of Science ®Google Scholar
• HerculesBLGayedIILucasSBJeacockJPeripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laserBr J Ophthalmol1977619555563336079
   PubMed Web of Science ®Google Scholar
• No authors listedPhotocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findingsOphthalmology197885182106345173
   PubMed Web of Science ®Google Scholar
• HoTSmiddyWEFlynnHWJrVitrectomy in the management of diabetic eye diseaseSurv Ophthalmol19923731902021475753
   PubMed Web of Science ®Google Scholar
• SabrosaNASurgical Management of Diabetic Retinopathy [webpage on the Internet]Newtown SquareReview of Ophthalmology2009 Available from: http://www.reviewofophthalmology.com/content/d/retinal_insider/i/1218/c/22941/Accessed July 6, 2015
   Google Scholar
• The Diabetic Retinopathy Vitrectomy Research GroupEarly vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research GroupArch Ophthalmol198510311164416522865943
   PubMedGoogle Scholar
• No authors listedEarly vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5Arch Ophthalmol199010879589642196036
   PubMedGoogle Scholar
• El-AsrarAMAl-MezainHSPharmacologic vitreolysis in diabetic retinopathyCurr Pharm Biotechnol201112340640920939804
   PubMed Web of Science ®Google Scholar
• LiCChenPZhangJEnzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1α pathwayInvest Ophthalmol Vis Sci20135474964497023847321
   PubMed Web of Science ®Google Scholar
• OpereCAO’BrienKKSheaJLUnderstanding diabetic retinopathyUS Pharm20113644652
   Google Scholar
• KampikALaser, intravitreal drug application, and surgery to treat diabetic eye diseaseOman J Ophthalmol20136Suppl 1S26S3124391369
   PubMedGoogle Scholar
• OzdekSUnluMGurelikGHasanreisogluBIntravitreal anti-VEGF therapy as an adjunct to laser photocoagulation for severe aggressive posterior retinopathy of prematurityJ Optom2013615159
   Google Scholar
• LiuYWangMMorrisADGlycemic exposure and blood pressure influencing progression and remission of diabetic retinopathy: a longitudinal cohort study in GoDARTSDiabetes Care201336123979398424170761
   PubMed Web of Science ®Google Scholar
• GoyalSLavalleyMSubramanianMLMeta-analysis and review on the effect of bevacizumab in diabetic macular edemaGraefes Arch Clin Exp Ophthalmol20112491152720665044
   PubMed Web of Science ®Google Scholar
• GroverDLiTJChongCCIntravitreal steroids for macular edema in diabetesCochrane Database Syst Rev20081CD005656
   Google Scholar
• TsilimbarisMKPandeleondidisVPanagiototglouTIntravitreal combination of triamcinolone acetonide and bevacizumab (Kenacort-Avastin) in diffuse diabetic macular edemaSemin Ophthalmol200924622523019954371
   PubMed Web of Science ®Google Scholar
• SunWOatesPJCoutcherJBGerhardingerCLorenziMA selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathyDiabetes200655102757276217003340
   PubMed Web of Science ®Google Scholar
• HottaNKawamoriRFukudaMShigetaYAldose Reductase Inhibitor-Diabetes Complications Trial Study GroupLong-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathyDiabet Med201229121529153322507139
   PubMed Web of Science ®Google Scholar
• No authors listedA randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research GroupArch Ophthalmol19901089123412442119168
   PubMedGoogle Scholar
• van GervenJMBootJPLemkesHHvan BestJAEffects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trialDoc Ophthalmol19948743553657851219
   PubMed Web of Science ®Google Scholar
• Wilkinson-BerkaJLWraightCWertherGThe role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathyCurr Med Chem200613273307331717168853
   PubMed Web of Science ®Google Scholar
• AlzaidAADinneenSFMeltonLJ3rdRizzaRAThe role of growth hormone in the development of diabetic retinopathyDiabetes Care19941765315348082520
   PubMed Web of Science ®Google Scholar
• GrantMBMamesRNFitzgeraldCThe efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled studyDiabetes Care200023450450910857943
   PubMed Web of Science ®Google Scholar
• SönksenPHRussell-JonesDJonesRHGrowth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future?Horm Res1993401–368798300053
   PubMedGoogle Scholar
• HattoriNMorideraKIshiharaTHinoMIkekuboKKurahachiHIs growth hormone associated with diabetic retinopathy?J Diabetes Complications19937112148481545
   PubMedGoogle Scholar
• KirkegaardCNørgaardKSnorgaardOBekTLarsenMLund-AndersenHEffect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in type I (insulin-dependent) diabetes mellitusActa Endocrinol (Copenh)199012267667722197845
   PubMedGoogle Scholar
• BloomgardenZTDiabetic retinopathy and diabetic neuropathyDiabetes Care200730376076517327356
   PubMed Web of Science ®Google Scholar
• BergerhoffKClarCRichterBAspirin in diabetic retinopathy. A systematic reviewEndocrinol Metab Clin North Am200231377979312227131
   PubMed Web of Science ®Google Scholar
• The DAMAD Study GroupEffect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trialDiabetes19893844914982647556
   PubMed Web of Science ®Google Scholar
• ZhengLHowellSJHatalaDAHuangKKernTSSalicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathyDiabetes200756233734517259377
   PubMed Web of Science ®Google Scholar
• SahooSBaruaAMyintKTHaqAAbasABNairNSTopical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedemaCochrane Database Syst Rev20152CD010009
   Google Scholar
• KaurSYangzesSSinghSSachdevNEfficacy and safety of topical difluprednate in persistent diabetic macular edemaInt Ophthalmol Epub2015822
   Web of Science ®Google Scholar
• KumarBTo Study Protective Effects of Bioflavonoids on Retinal Neurovascular Degeneration in Diabetic Rats [doctoral thesis synopsis]New DelhiUniversity of Delhi2003 Available from: http://shodhganga.inflibnet.ac.in/bitstream/10603/26842/19/19_synopsis.pdfAccessed September 1, 2015
   Google Scholar
• DedaniaVSBakriSJNovel pharmacotherapies in diabetic retinopathyMiddle East Afr J Ophthalmol201522216417325949073
   PubMedGoogle Scholar
• KumarBGuptaSKSaxenaRSrivastavaSCurrent trends in the pharmacotherapy of diabetic retinopathyJ Postgrad Med201258213213922718058
   PubMed Web of Science ®Google Scholar